320 related articles for article (PubMed ID: 18027869)
1. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
[TBL] [Abstract][Full Text] [Related]
2. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of p27(Kip1) is associated with malignant transformation of the rat urinary bladder epithelium.
Ogawa K; Kimoto N; Asamoto M; Nakanishi M; Takahashi S; Shirai T
Carcinogenesis; 2000 Jan; 21(1):117-21. PubMed ID: 10607743
[TBL] [Abstract][Full Text] [Related]
5. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
[TBL] [Abstract][Full Text] [Related]
7. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
[TBL] [Abstract][Full Text] [Related]
12. DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
Dahm HH; von der Haar C; RĂ¼bben H
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1253-60. PubMed ID: 27033373
[TBL] [Abstract][Full Text] [Related]
13. Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
Tamano S; Shirai T; Kawabe M; Ni-I H; Mori Y; Okada M; Fukushima S
Toxicol Pathol; 1992; 20(2):205-11. PubMed ID: 1475581
[TBL] [Abstract][Full Text] [Related]
14. Potential effects of the herbicide Diuron on mammary and urinary bladder two-stage carcinogenesis in a female Swiss mouse model.
de Moura NA; Grassi TF; Rodrigues MA; Barbisan LF
Arch Toxicol; 2010 Feb; 84(2):165-73. PubMed ID: 19902181
[TBL] [Abstract][Full Text] [Related]
15. Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Mitsuhashi M; Wanibuchi H; Morimura K; Doi K; Wei M; Wada S; Nakatani T; Fukushima S
Cancer Sci; 2003 Dec; 94(12):1052-8. PubMed ID: 14662020
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H
Jpn J Cancer Res; 2002 Jan; 93(1):42-9. PubMed ID: 11802807
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
[TBL] [Abstract][Full Text] [Related]
19. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
20. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]